VanEck Associates’s NEVRO CORP. NVRO Stock Holding History

VanEck Associates’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,516	Closed	-$127K	–	1475
2023 Q1	$127K	Buy	3,516 +872	+33%	+$30.6K	﹤0.01%	1218
2022 Q4	$105K	Buy	+2,644	New	+$110K	﹤0.01%	1243

Other funds holding NVRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

VanEck Associates's NVRO Position: Q2 2023 in Review

VanEck Associates sold out of NEVRO CORP. (NVRO) in Q2 2023, closing a stake of 3,516 shares — an estimated $127K sold.

VanEck Associates first reported a position in NVRO in Q4 2022 and held it in 2 quarters. The position peaked at $127K in Q1 2023. 155 funds tracked by Wall St. Rank hold NVRO as of Q2 2023.

VanEck Associates reported no remaining NEVRO CORP. position as of Q2 2023 after selling out during the quarter.
VanEck Associates sold 3,516 NEVRO CORP. shares in Q2 2023, an estimated $127K.
VanEck Associates first reported a position in NEVRO CORP. in Q4 2022 and held it in 2 quarters.
VanEck Associates's NEVRO CORP. position peaked at $127K in Q1 2023.
155 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2023.

Based on VanEck Associates's 13F filing for Q2 2023, filed 3 Aug 2023.